Table 1 |
||
|
Animal studies assessing possible therapeutic interventions for neurogenic pulmonary edema (NPE) |
||
|
Intervention |
Animal model |
Study design/results |
|
|
||
|
Alpha Blockade |
||
|
Phentolamine (1 mg/kg) |
Rats |
Prevented pulmonary edema after induced injury to anterior hypothalamus [23] |
|
Phenoxybenzamine (3 mg/kg) |
Dogs |
Prevented pulmonary artery and systemic pressure increase after CSF pressure was increased from 100 to 200 mmHg [22] |
|
Phenoxybenzamine (1.5 mg/kg) |
Dogs |
Prevented increases in pulmonary perfusion pressure and PVR and associated increases in lung water, Qs/Qt, VD, and hypoxemia induced by ICP elevation [50] |
|
Phentolamine (2 mg/kg) |
Sheep |
Prevented the expected increase in permeability and lymph flow after CNS insult [38] |
|
Beta Blockade |
||
|
Propranolol (0.5 mg/kg) |
Dogs |
Pulmonary artery and systemic pressure unchanged with use of beta blocker after CSF pressure was increased from 100 to 200 mmHg [22] |
|
Propranolol (1.5 mg/kg) |
Dogs |
Pretreatment with beta blocker attenuated the increase in PVR during elevation in ICP but did not prevent increases in lung water, Qs/Qt, VD, and hypoxemia [50] |
|
Sympathetic Outflow Denervation |
||
|
Bilateral thoracic sympathectomy |
Dogs & Rabbits |
Sympathectomy prior to induced CNS insult did not prevent pulmonary pressure elevation [35] |
|
Spinal cord transection |
Monkeys |
NPE prevented by sympathetic denervation [18] |
|
Cholinergic Influence |
||
|
Vagotomy |
Dogs & Rabbits |
Vagotomy did not prevent increases in pulmonary vascular pressures [35] |
|
Vagotomy |
Monkeys |
Vagotomy did not prevent NPE [18] |
|
Other |
||
|
Methylprednisone (40 mg/kg) |
Rats |
Prevented aconitine induced NPE and systemic HTN [51] |
|
Hypovolemia |
Rats |
Lowering pulmonary blood volume by phlebotomy prevented aconitine induced NPE [51] |
|
Naloxone |
Sheep |
Induced NPE could be prevented by opiate antagonism, suggesting a role for endorphins [45] |
|
|
||
|
CNS, central nervous system; CSF, cerebrospinal fluid; PVR, pulmonary vascular resistance; Qs/Qt, pulmonary shunt; VD, dead space. |
||
|
Davison et al. Critical Care 2012 16:212 doi:10.1186/cc11226 |
||